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Abstract : 
The habilitation thesis focuses on arbovirus-induced disease of the central nervous system, 
with emphasis on those agents important and emerging in Europe, by giving an overview of 
their epidemiology, diagnostics, and surveillance. These are: West Nile virus (WNV), 
Toscana virus (TOSV), and tick-borne encephalitis virus (TBEV). The published studies 
selected are all part of activities within the European Network for Diagnostics of ‘Imported’ 
Viral Diseases (ENIVD) and/or the German Consultant Laboratory for Tick-borne encephalitis 
and further flaviviruses. 
 
Abstrakt : 
P edkládaná habilita ní práce je zam ena na arbovirová onemocn ní centrální nervové 
soustavy. Zvláštní d raz je kladen na v Erop  emergentní virová agens a jejich 
epidemiologii, diagnostiku a surveillanci. Z nich pak zejména na virus západního Nilu, virus 
Toscana a virus klíš ové encefalitidy. Vybrané publikace, které jsou sou ástí habilita ní 
práce, vznikly v rámci aktivit Evropské sít  pro diagnostiku importovaných virových infekcí 
(European Network for Diagnostics of ‘Imported’ Viral Diseases (ENIVD)) a/nebo p i innosti 
N mecké konzulta ní laborato e pro klíš ovou encefalitidu a další flaviviry.  
 
 
Prohlašuji, že jsem svou habilita ní práci vypracoval samostatn  pouze s použitím pramen  
a literatury uvedených v seznamu citované literatury. P iložené práce vznikly v rámci aktivit 
Evropské sít  pro diagnostiku importovaných virových infekcí (European Network for 
Diagnostics of ‘Imported’ Viral Diseases (ENIVD)) a/nebo p i innosti N mecké konzulta ní 
laborato e pro klíš ovou encefalitidu a další flaviviry. 
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“Science cannot solve the ultimate mystery of nature.  
And that is because, in the last analysis, we ourselves are part of nature 
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Chapter I.  
Introduction and literature review 
 
I.1 Arbovirus encephalitis 
 
I.1.1 Arboviruses 
The World Health Organization (WHO) defines arboviruses (arthropod-borne viruses) 
as a group of viruses which are maintained in nature principally, or to an important 
extent, through biological transmission between susceptible vertebrate hosts by 
hematophagous (blood feeding) arthropods including mosquitoes, ticks, and flies 
(http://www.who.int/vaccine_research/diseases/vector/en/). The term ‘arbovirus’ has 
no taxonomic significance. It is an informal term that refers to the biological-
ecological similarities of these heterogeneous viruses. All arboviruses are maintained 
in complex life cycles [see examples in chapter I.2] involving at least one non-human 
primary vertebrate host and one primary arthropod vector. The viruses multiply and 
produce viremia in reservoir vertebrate hosts, multiply in the tissues of competent 
arthropod vectors, and are transmitted in saliva to new vertebrates by the bites of 
arthropods after a period of extrinsic incubation (Davis et al., 2008; Preiser, 2010; 
Weaver and Reisen, 2010). These cycles usually remain undetected until humans 
appear in a natural focus, or the virus escapes from this focus by a secondary vector 
or vertebrate host as the result of ecological changes. Humans and domestic animals 
can develop clinical symptoms but usually are ‘dead-end’ hosts because they do not 
produce significant viremia, and therefore do not contribute to the natural 
transmission cycle. 
Over 500 different arboviruses are catalogued (Karabatsos, 1985; van Regenmortel 
et al., 2000; Tsai and Chandler, 2003; Hayes et al., 2008), of which some 100 are 
known to cause human disease, with clinical signs such as acute self-limiting fever 
(with or without rash), muscle and joint pain (e.g. chikungunya disease), hemorrhagic 
symptoms (e.g. dengue hemorrhagic fever) and/or neurological illness (e.g. tick-
borne encephalitis). Not all arboviruses are restricted to the tropics, and only a 
subset of these involves the central nervous system (CNS), causing symptoms 
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ranging in severity from mild aseptic meningitis to encephalitis or flaccid paralysis. 
However, most human arboviral infections are clinically bland or result in an 
asymptomatic infection associated with seroconversion. Table 1 gives an overview of 
the most important encephalitic arboviruses worldwide which are formally classified in 
different families and genera based on their morphology, nature/structure of the 
genome, serological relationship, and biological properties. All encephalitic 
arboviruses are small, simple RNA viruses ranging in size from 40–60 nm for 
Flaviviridae, 60–80 nm for Togaviridae and Reoviridae to 80–120 nm for 
Bunyaviridae (Modrow et al., 2003). Alphaviruses and flaviviruses are enveloped 
spherical viruses whose genome consists of a positive-sense (+), single-stranded 
(ss) RNA molecule of 9–12 kb. Bunyaviridae are enveloped spherical/pleomorphic 
viruses whose genomes consist of three linear minus-sense (-) ssRNA segments of 
approximately 11 kb. And Reoviridae are non-enveloped icosahedral-shaped viruses 
that can contain up to 12 double-stranded linear RNA segments totaling 19–32 kb 
(Condit, 2007). All arboviruses, except for those belonging to the Reoviridae, have 
nucleocapsids surrounded by a host cell-derived lipid bilayer in which several viral 
envelope or membrane proteins are inserted that play an important role in viral 
attachment and cell entry, which is not well known at all. In the case of Reoviridae, 
the surface proteins are part of the outer capsid layer. Antibodies to these proteins 
form the basis for host immunity and serological diagnostics.   
The habilitation thesis focuses on arboviruses inducing CNS disease, with emphasis 
on those agents important and emerging in Europe, by giving an overview of their 
epidemiology, diagnostics, and surveillance. These are: West Nile virus (WNV), 
Toscana virus (TOSV), and tick-borne encephalitis virus (TBEV). The published 
studies selected are all part of activities within the European Network for Diagnostics 
of ‘Imported’ Viral Diseases (ENIVD) and/or the German Consultant Laboratory for 
Tick-borne encephalitis and further flaviviruses. Fact sheets and further information 
concerning arbovirus encephalitis can be found on the respective websites of these  








Encephalitis is an irritation and inflammation of the brain parenchyma, associated 
with clinical evidence of brain dysfunction (Whitley and Gnann, 2002; Romero and 
Newland, 2003; Lewis and Glaser, 2005; Granerod and Crowcroft, 2007; Steiner et 
al., 2010). It often coexists with inflammation of the covering membranes of the brain 
and spinal cord (‘meningoencephalitis’). Meningeal irritation (e.g. fever, headache, 
general malaise, vomiting) and somnolence are signs of meningitis, while behavioral, 
cognitive, and focal neurological symptoms and seizures are signs of the disruption 
of brain function. Like meningitis, encephalitis can be caused by a wide variety of 
infectious agents, including viruses, bacteria, fungi, and parasites as a result of direct 
CNS invasion (Whitley and Gnann, 2002; Lewis and Glaser, 2005; Granerod and 
Crowcroft, 2007; Donoso Mantke et al., 2008 a). Other types of encephalitis include 
acute parainfectious or post-vaccination encephalitis, i.e., acute disseminated 
encephalomyelitis (ADEM), sub-acute and chronic encephalitis, and 
encephalopathies due to non-infectious causes (e.g. intoxications, drugs, systemic 
organ dysfunction, or systemic infection sparing the brain). Those cases of aseptic 
encephalitis for which the etiology can be determined are most often caused by viral 
infections: herpes simplex viruses, varicella-zoster virus, Epstein-Barr virus, mumps 
virus, measles virus, and enteroviruses are considered to be the major causes of viral 
encephalitis in immunocompetent individuals worldwide (Nicolosi et al., 1986; 
Rantala and Uhari, 1989; Kamei and Takasu, 2000; Koskiniemi et al., 2001; Davison 
et al., 2003; Glaser et al., 2003; Lee et al., 2003; Glaser et al., 2006; Ilias et al., 2006; 
Mailles and Stahl, 2009). In addition to these common pathogens, which are 
responsible for ‘acute sporadic encephalitis’, arboviruses can cause ‘acute epidemic 
encephalitis’ with similar symptoms to those of herpes simplex encephalitis (HSE), 
being among the major etiologies associated with encephalitis, depending on 
regional/endemic situation and on environmental factors (Okuno et al., 1975 a; 
Okuno et al., 1975 b; Chunsuttiwat, 1989; Cizman and Jazbec, 1993; Günther et al., 
1997; Wu et al., 1999; Solomon and Cardosa, 2000; Akiba et al., 2001; Khetsuriani et 
al., 2002; Kunze et al., 2004; Trevejo, 2004; Kari et al., 2006; Kupila et al., 2006; 
Tyler, 2009 a). Important non-arthropod-borne viral zoonotic pathogens affecting the 
CNS are lymphocytic choriomeningitis virus (transmitted by rodents), rabies virus 
(transmitted by terrestrial mammals or bats), and Nipah virus (transmitted by bats 
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and pigs) (Whitley and Gnann, 2002; Romero and Newland, 2003; Tyler, 2009 a; 
Tyler, 2009 b). Finally, non-viral infective causes of encephalitis may include such 
diseases as tuberculosis, rickettsial disease, and trypanosomiasis which should be 
taken into consideration for differential diagnosis (Steiner et al., 2010). However, it 
should be mentioned that encephalitis is a rare manifestation of human viral infection, 
but of public health importance worldwide due to its high morbidity and mortality.     
 
I.1.3 Pathogenesis 
The pathogenesis of acute viral encephalitis is diverse and not fully understood. 
Pathogens infecting the brain directly must gain access to the CNS first. This can 
occur by either hematogenous or neuronal routes (Johnson and Mims, 1968; 
Johnson, 1987; Johnson, 1998). Hematogenous spread is most common and can 
result in an altered blood–brain barrier (BBB), as exemplified by arboviral infections 
of which those caused by alphaviruses, flaviviruses, and Bunyaviridae are the ones 
best known (Chambers and Diamond, 2003; Dionisio et al., 2003; Cusi et al., 2005; 
Mandl, 2005; Davis et al., 2006; Diamond, 2009; Hollidge et al., 2010; R žek et al., 
2010).  
In general, arboviral infections occur most frequently following the bite of an infected 
arthropod. The arboviruses are transmitted by saliva from the arthropod salivary 
glands. The amount of virus required to infect humans is unknown. The route of 
progression through the host is not clearly established, but it appears that upon 
inoculation of virus into the skin, initial infection and peripheral amplification occur in 
subcutaneous tissues and lymph nodes, allowing the virus to enter the bloodstream 
(primary viremia) (Malkova and Frankova, 1959). Dendritic cells in the skin are 
thought to be the first cells for viral replication and to transport the virus to nearby 
draining lymph nodes via the lymphatic system (Johnston et al., 1996; Johnston et 
al., 2000). Flaviviruses enter the cell via receptor-mediated endocytosis. Fusion of 
the viral membrane with the endosomal vesicle membrane occurs after exposure to 
low pH in the endosome, following internalization through a class II fusion 
mechanism identical to the one formed in alphaviruses and Bunyaviridae (Kielian, 
2006; Plassmeyer et al., 2007). Viremia is further augmented by dissemination of 
virus to the reticuloendothelial system and sometimes to muscle (secondary viremia). 
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During the viremic phase, many extraneural tissues can be infected (e.g. spleen, 
liver, and bone marrow), and the release of the virus from these tissues enables the 
viremia to continue for several days (Albrecht, 1968). A main principle that applies is 
the relationship between peripheral virus burden and the tendency to cause 
neuroinvasion. Viruses with a low capacity to generate viremia in peripheral tissue 
can be classified as low in ‘neuroinvasiveness’ (capacity to enter the CNS) 
regardless of their intrinsic level of ‘neurovirulence’ (replication within the CNS) 
(Chambers and Diamond, 2003). A relationship between systemic virus burden and 
viremia is also apparent, with the potential of the virus to generate viremia being a 
correlate of neuroinvasion. Factors like time of onset, magnitude, and duration of 
viremia, as well as the integrity of the host’s innate (complement and interferon), 
humoral, and cell-mediated immunity, also influence the viral dissemination and risk 
of entry into the CNS. Encephalitis tends to be a rare complication after viremia 
because access to the brain is carefully regulated at the BBB. The mechanisms used 
by the virus to cross the BBB and to enter the CNS are not completely understood. 
Several hypotheses have been postulated for mechanisms of CNS penetration: (i) 
transport (transcytosis) across the vascular endothelial cells or infection of these and 
other cells constituting the BBB (Dropuli  and Masters, 1990; Lossinsky and Shivers, 
2004); (ii) access to the CNS after loss of BBB integrity (Lustig et al., 1992; Lossinsky 
and Shivers, 2004); or (iii) entry through the highly susceptible olfactory bulb (Monath 
et al., 1983; Cook and Griffin, 2003). An alternative mechanism, typically used by 
herpes simplex virus, might be direct axonal retrograde transport from infected 
peripheral neurons. This strategy may be successful because pathogens travelling 
inside neurons avoid immune surveillance. Once a pathogen has entered the brain, a 
variety of anatomic sites can become infected. For example, WNV typically infects 
neurons in the brainstem (Gyure, 2009); TOSV predominantly affects the gray matter 
of deep nuclei and hippocampus (Cusi et al. 2005); and TBEV affects the spinal cord, 
brainstem, and cerebellum (R žek et al., 2010). These observations might be 
characteristic but are not disease-specific due to substantial overlap of the 
topographic patterns of CNS infection between the viruses. At least, only laboratory 
diagnostics is reliable enough to identify the causative virus [see chapter I.3]. 
Neurologic signs and symptoms develop after infection as the result of direct 
necrosis, host inflammatory response, and/or apoptosis in certain regions of the 
CNS. Neuronal apoptosis is a hallmark of several viral encephalitides, including 
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those caused by WNV, TOSV, and TBEV (Shrestha et al., 2003; Cusi et al., 2005; 
R žek et al., 2009). Knowledge of the natural history of neurological arboviral 
infections as well as of shared mechanisms of neuroinvasion and neurovirulence is 
important to control the spread of these pathogens and for the development of 
effective treatment measures and vaccines. Notably, pro-apoptotic, host-protein 
synthesis inhibitory, and type I interferon-blocking properties have been attributed to 
several non-structural proteins of arboviruses from different families. This suggests 
that the ability of these viruses to induce death and subvert the innate immune 
system is critical for their maintenance in nature and may hold the key to uncovering 
shared mechanisms of neuropathogenesis (Billecocq et al., 2004; Blakqori et al., 
2007; Yin et al., 2009, Overby et al., 2010). Animal models have been established for 
providing insight into the way virus-specific and host factors influence the course of 
disease, with the mouse model having become a fundamental tool for studying viral 
pathology as well as for the development of vaccines and antivirals (Chambers and 
Diamond, 2003; Nalca et al., 2003; Shrestha et al., 2003; Cusi et al., 2005; Mandl, 
2005; Holbrook and Gowen, 2008; R žek et al., 2010).  
 
I.1.4 Clinical features 
Because encephalitis has so many underlying causes as described above, it is nearly 
impossible to make generalizations about clinical signs and symptoms. However, the 
clinical hallmark of acute viral encephalitis is fever accompanied by headache, a 
subsequently altered level of consciousness, and symptoms and signs of cerebral 
dysfunction. These may consist of abnormalities that can be categorized into 
cognitive dysfunction (acute disturbances of memory, speech, and orientation, etc.); 
behavioral changes (disorientation, hallucinations, psychosis, personality changes, 
agitation); focal neurological abnormalities (e.g. anomia, dysphasia, hemiparesis); 
and seizures. The presented signs and symptoms may suggest whether acute 
encephalitis is focal or diffuse (Chaudhuri and Kennedy, 2002; Steiner et al., 2010). 
Distribution and spread of histopathological changes in the CNS are important for 
etiologic considerations: four types of meningoencephalitis may be distinguished, 
affecting either only the meninges, or the gray matter or the white matter, or both, in 
a focal or a diffuse manner (Love and Wiley, 2008). For example, as a rough guide, 
mostly arboviral encephalitis has diffused brain involvement, and early fever, 
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vomiting, obtundation, and coma are typical. In contrast, herpes simplex encephalitis 
(HSE) can begin focally with hemiparesis, seizures, or cranial nerve defects. While 
acute encephalitis results from direct CNS invasion by an offending pathogen (with 
the gray matter often targeted), in post- or parainfectious encephalitis neurologic 
effects are the consequence of the host immune response (which often affects the 
white matter). From a clinician’s point of view, a ‘typical’ arboviral infection runs a 
biphasic course. However, this only occurs in a minority of persons infected with an 
arbovirus. In most patients, the clinical presentation does not follow this pattern and 
is said to be ‘atypical’. Usually, the incubation period is very short: 3 to 8 days, 
sometimes a little longer (Davis et al., 2008). Initially, there is a flu-like syndrome with 
fever, headache, fatigue, muscle and joint pain. Patients often have malaise and 
gastrointestinal signs (such as anorexia, nausea, vomiting, diarrhea, abdominal 
pain). Sometimes there is pharyngitis, rhinitis and swollen lymph nodes (as reviewed 
for different viruses by Figueiredo, 2000; McCormack and Allworth, 2002; Davis et 
al., 2008; Hubálek, 2008; Gyure, 2009; Depaquit et al., 2010; Dobler, 2010; Misra 
and Kalita, 2010; R žek et al., 2010; Zacks and Paessler, 2010). A maculopapular 
rash on the chest, back, and upper extremities can occur with variable frequency as 
a common symptom in WNV infection. The initial phase of infection can also take a 
subclinical course. Most individuals infected with arboviruses develop an 
asymptomatic infection, although the exact ratio of neuroinvasive disease cases to 
asymptomatic infections varies for specific viruses, and is roughly estimated between 
1:100 and 1:1000 (Davis et al., 2008). For most arboviruses, asymptomatic infections 
occur mainly in children and young adults. The resulting infection usually produces 
prolonged immunity. It should be remembered that asymptomatically infected 
individuals can still transmit the infection to others, e.g. by blood transfusion. The 
arboviral disease usually does not go further than the first described phase and thus 
does not come to the attention of the clinician. Then it is not possible to make a 
diagnosis unless there is an epidemic or if unusually good laboratory facilities are 
available. In a minority of patients, after a transient improvement of the general 
symptoms there is a second phase of the disease. Again there is fever (the pattern of 
fever is therefore biphasic, so the patient fulfils the criteria for a typical case). Again 
there are flu-like symptoms which may be more pronounced than in the variable 
prodromal stage. Patients presenting with headache, fever, and neck stiffness 
without focal weakness or altered mental status are classified as having meningitis. 
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Patients presenting with clinical or laboratory evidence of brain parenchymal 
involvement are classified as having encephalitis. Encephalitic signs and symptoms 
can include depressed concentration, memory impairment, somnolence, confusion, 
dizziness, disorientation, nausea, vomiting, lethargy, stupor, tremors, convulsions, 
myoclonus, photophobia, dysphagia, dysarthria, nystagmus, vertigo, limb or facial 
pains and weakness, paresthesia, alteration in sensory, behavioral abnormalities, 
and generalized or localized seizures (as reviewed for different viruses by 
Figueiredo, 2000; McCormack and Allworth, 2002; Davis et al., 2008; Hubálek, 2008; 
Gyure, 2009; Depaquit et al., 2010; Dobler, 2010; Misra and Kalita, 2010; R žek et 
al., 2010; Zacks and Paessler, 2010). Extrapyramidal signs including Parkinsonism, 
increased muscle tone, and tremors occur with variable frequency in patients with 
alphavirus and flavivirus encephalitis. Altered mental status is a hallmark of all 
encephalitides. Development of coma and death also occur with variable frequency 
among arbovirus infections (see Table 1). In contrast to other arboviral 
encephalitides, neuromuscular weakness is often a prominent finding in WNV 
meningoencephalitis, occurring in up to 50% of patients. Clinical syndromes that 
have been described include an acute flaccid paralysis/poliomyelitis-like syndrome, a 
Guillain-Barré-like syndrome, and a generalized myeloradiculitis (Tyler, 2004; Sejvar 
et al., 2005; Debiasi and Tyler, 2006). The acute flaccid paralysis/poliomyelitis-like 
syndrome, as a result of anterior horn cell death in the spinal cord, has been 
characterized best clinically and presents as acute monoplegia, asymmetric upper or 
lower extremity weakness, or generalized asymmetric tetraplegia or quadriplegia. In 
general, the acute encephalitis phase lasts 1 to 3 weeks but convalescence is slow. 
Depending on the severity of the disease, neurological and/or neuropsychiatric 
symptoms may persist for months. However, it should be noted that clinical 
presentation and course of infection can be markedly variable, and that findings from 
a general clinical examination are not of sufficient diagnostic value to identify the 
causative virus.  
 
I.1.5 Therapy and prevention 
Currently, there are no specific antiviral therapies of proved efficacy available for any 
arbovirus infection (Steiner et al., 2010). Few drugs that have shown efficacy in 
experimental animal studies and infected cell cultures, particularly when administered 
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early after viral infection, include interferon (Brooks and Phillpotts, 1999; Pantelic et 
al., 2005), ribavirin (Morrey et al., 2002), monoclonal antibodies (Kimura-Kuroda and 
Yasui, 1988; Morrey et al., 2007), immune globulin (Ben-Nathan et al., 2003), and 
antisense oligomers that bind to arboviral RNA (Bia et al., 1980; Kumar et al., 2006). 
Ensuring the presence of the drugs in sufficient concentration throughout the brain 
will be crucial in a clinical setting, where drug administration can begin only after the 
appearance of clinical symptoms. A significant issue for the development of effective 
therapies for the treatment of viral encephalitis is the ability of the therapeutic agent 
to cross the BBB and limit virus replication or the host immune response (Strazielle 
and Ghersi-Egea, 2005; Pardridge, 2007). In the absence of viable specific antiviral 
therapy, treatment relies on supportive management. All cases of acute viral 
encephalitis require hospitalization and supportive care based on syndrome severity 
(Chaudhuri and Kennedy, 2002). Seizures are controlled with intravenous 
anticonvulsants. Careful attention must be paid to the maintenance of respiration, 
cardiac rhythm, fluid balance, prevention of deep vein thrombosis and aspiration 
pneumonia, and to the medical management of raised intracranial pressure and 
secondary bacterial infections. Because of the limited risk of human-to-human 
transmission of infection, isolation of patients with arbovirus encephalitis is usually 
not required, although general precautions should be taken because both blood and 
cerebrospinal fluid (CSF) are potentially infectious. Many patients require 
rehabilitation following encephalitis. Vaccines are available for a limited number of 
arboviruses with a potential to cause encephalitis, and there is a significant need for 
vaccine development (Nalca et al., 2003). Approved vaccines for humans are only 
available against Japanese encephalitis and tick-borne encephalitis (Mansfield et al., 
2009; Halstead and Thomas, 2010; Heyman et al., 2010). A vaccine under 
‘investigational new drug application’ for Venezuelan equine encephalitis is available 
in the United States, but exclusively for the US Army, and at great expense. There 
are also new vaccines under investigation for Eastern and Western equine 
encephalitis, but these are typically given only to laboratory workers, and also difficult 
to obtain (Holbrook and Gowen, 2008). For other causative pathogens (e.g. WNV), 
vaccines are in clinical trials (Martina et al., 2010). Otherwise, preventive measures 
against arbovirus infections are entirely environmental, including sanitation, vector 
control, education, and avoidance aspects.  
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I.1.6 Arboviruses as emerging threats 
Arboviruses are distributed worldwide, representing nearly 30% of all emerging 
infectious diseases in the last decade (Jones et al., 2008; Tyler, 2009 a). While the 
variables contributing to the epidemiology of each virus are unique, influencing the 
pathogen transmission within the natural life cycle (related to the triad virus–vector–
host), there are some common socio-economic, environmental, and ecological 
factors contributing to the emergence of arboviral diseases (Morens et al., 2004). In 
particular, (re-)emergent infectious viruses can form by variation of previously present 
agents (genetic mutation and/or recombination), changes in populations of reservoir 
hosts or intermediate insect vectors, microbial adaption from animal to human hosts, 
changes in human demographics and behavior (notably urbanization, travel, leisure 
activities), and environmental factors. Also, the introduction of new infective agents to 
a determined area can be significant (Weaver and Reisen, 2010). This may occur 
directly from person to person or indirectly through arthropod vectors or other carrier 
animals, and sometimes by the transport of goods (Sutherst, 2004). Finally, the effect 
of climate changes has been increasingly discussed to have an influence on the (re-) 
emergence of infectious diseases (Reiter, 2008; Gould and Higgs, 2009; Stark et al., 
2009). In the near future climate and environmental changes in the form of rising 
temperatures and humidity will probably play a major role to promote vector-borne 
diseases, but it would be over-simplifying the complex interrelation by relating the 
emergence of arboviruses only to climate changes. This is a multi-variate system 
where microbial, host, and environmental factors interact to create opportunities for 
infectious agents to evolve in new ecological niches, reach and adapt to new hosts, 
and spread more easily between them (Table 2). 
WNV, TOSV, and TBEV were identified to be among the main (re-) emergent viral 
infections in Europe (Pugliese et al., 2007 a; Vorou et al., 2007). Knowledge about 
the true prevalence and incidence of these pathogens needs to be expanded and 
regularly updated in order to identify the risk for the exposed population and to apply 
optimal preventive measures. From the public health view, it is important to enhance 
surveillance activities (reporting incidence of human diseases, vector surveillance, 
domestic and wild animal surveillance, monitoring of ecological factors); diagnostic 
capability (test establishment and quality control); and response to vector-borne 
diseases (vector control, personal protection, therapies, and vaccines) (Senior, 
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Table 2 Factors contributing to emergent and re-emergent viral infections* 
• Global climate change
• Changes in human demographics and behavior (e.g. increasing leisure activities in nature)
• Environmental changes, incl. heavy rains followed by flood, and rehabilitation of wetlands
  (increased incidence of mosquito-vector populations)
• Introduction of exotic agents by human and animal migration
• Poverty
• Economic development, land use, and technology
• Tourism and business travels (travel-associated importation of rare and severe infections)
• Global trade in wildlife
• Animal smuggling (especially of birds)
• Genetic mutations and/or recombinations producing dangerous strains
• Adaptation of animal viruses to human host
• Human suscepility to infection
• Breakdown of public health measures
* Selected factors contributing to the emergence and re-emergence of infectious diseases, incl.
genetic, biological, and socio-economic factors (Morens et al., 2004; Pugliese et al., 2007 a).
2008). Chapter I.4 deals with the key requirements for a European surveillance 
system, including improvement of diagnostic methods as valuable tools in the 
accurate estimation of the prevalence and incidence especially regarding WNV, 
TOSV, and TBEV as important emerging arboviral causes of encephalitis. Depending 
on the regional/endemic situation of European countries or on special incidents, other 
less common arboviral agents causing encephalitis, like Tahyna virus (Rudolf et al., 
2008); ‘imported’ arboviral agents causing encephalitis, usually with other clinical 
hallmarks, like chikungunya virus or dengue virus (Donoso Mantke et al., 2004; 
Lemmer et al., 2004; Donoso Mantke et al., 2007 a; Niedrig et al., 2009; Panning et 
al., 2009; Domingo et al., 2010); or arboviruses recently identified to be human-
pathogenic, like Usutu virus (Cavrini et al., 2009; Pecorari et al., 2009), might be 
considered for surveillance activities, but will not be further attended to in this thesis. 
       
 
I.2 Epidemiology of encephalitic arboviruses important for Europe 
 
I.2.1 West Nile virus 
WNV is a mosquito-transmitted flavivirus which belongs to the Japanese encephalitis 
serogroup of the family Flaviviridae. It is by far one of the most widespread 
13 
arboviruses (Hayes et al., 2005; Gyure, 2009; Reiter, 2010). Based on signature 
amino acid substitutions or deletions in their envelope proteins, WNV isolates are 
assigned into at least two main lineages which are about 30% divergent (Berthet et 
al., 1997; Lanciotti et al., 1999). Lineage I, which can produce disease in humans, 
horses, and birds, includes virus strains from Africa, the Middle East, Europe, India, 
Australia (clade: Kunjin), and the Americas. In contrast, lineage II contains strains 
historically isolated in sub-Saharan Africa and Madagascar, and recently in Hungary, 
Russia, and Austria (Campbell et al., 2002; Bakonyi et al., 2006; Erdélyi et al., 2007; 
Platonov et al., 2008). So far, this lineage has been considered as non-pathogenic in 
humans and horses. Nevertheless, recent data show that South African strains 
belonging to lineage II were able to induce severe clinical symptoms in both humans 
and horses (Venter et al., 2009). At least six lineages have been proposed for strains 
isolated in Europe, Russia, and India (Lvov et al., 2004; Bakonyi et al., 2005; Bondre 
et al., 2007; Kramer et al., 2008; Vazquez et al., 2010), and in addition a distinct 
genotype lineage I was identified in the United States (US), probably representing the 
dominant strain in North America (Davis et al., 2005; Snapinn et al., 2007). WNV is 
mainly maintained in a life cycle between birds, especially passerines (perching 
birds) and charadriiformes (wader- or gull-like birds) as the most competent 
amplifying hosts judged by magnitude and duration of viremia, and ornithophilic 
mosquitoes, especially of the genus Culex as the preferred vectors (Hubálek and 
Halouzka, 1999; Dauphin et al., 2004; Reiter, 2010). Humans and other mammals, 
especially horses, can develop clinical illness but usually are incidental or dead-end 
hosts because they do not produce significant viremia, and thus do not contribute to 
the transmission cycle (Fig. 1). 
 
The mosquito vector species vary in their abundance in different geographic regions, 
in their tendency to feed on mammals, and in their efficiency to transmit infection. In 
Europe, four mosquito species are considered to be the dominant vector species, i.e. 
Culex pipiens, Cx. torrentium, Cx. modestus, and Coquillettidia richardii (Hubálek, 
2008; Reiter, 2010). Occasional vectors are Ochlerotatus cantans and Anopheles 
maculipennis. While natural foci are usually situated in a bird–mosquito cycle in 





























Figure 1 Natural transmission cycle and main geographical areas of WNV transmission  
Upper panel: Mosquitoes acquire infection while feeding on a viremic bird host. The likelihood that a feeding mosquito will 
become infected increases as the level of viremia inside the amplifying host increases. The virus passes through the gut wall 
into the hemolymph of the insect, after which replication occurs in most of the internal tissues. Once the salivary glands are 
infected, the virus can pass to a new host via saliva injected into the skin when the mosquito takes the next blood meal. In 
nature, the virus cycles between mosquito vectors and bird hosts. It must survive the winter to initiate new annual cycles of 
infection (overwintering). Possible mechanisms of overwintering include survival in hibernating female mosquitoes, vertical 
transmission from infected females to their progeny, continued transmission in warmer latitudes, and chronic infections in 
migratory birds. Ornithophilic vectors that also bite and infect mammals, including humans, are termed ‘bridge vectors’. Humans 
and horses are incidental hosts who can be infected by bridge vectors. Lower panel: Detection of WNV infection in different 
areas in Europe and in the Mediterranean basin (1962–present) has been done in: humans, birds, horses, and/or mosquitoes. 
There is further evidence of WNV transmission observed by past and recent serological surveys in humans, birds, or other 




Many species of wild birds might act as natural reservoir hosts for WNV. In Europe, 
this virus was isolated from Ardeola ralloides, Plegadis falcinellus, Anas querquedula, 
Fulica atra, Tringa ochropus, Vanellus vanellus, Larus ridibundus, Streptopelia turtur, 
Corvus corone, Corvus frugilegus, and Sturnus vulgaris, but the range of bird species 
might be much broader, as experimental and serological studies could show 
(Hubálek, 2008; Calistri et al., 2010; Reiter, 2010). Birds can be infected by a variety 
of routes other than mosquito bites (e.g. oral and fecal-oral infection), and different 
species may have different potential for virus maintenance and dispersion of the virus 
in nature. Migratory birds are considered to play an important role in the geographic 
introduction and spread of the virus. 
 
WNV was first isolated in 1937 from the blood of a febrile woman who lived in the 
West Nile sub-region in Uganda (Smithburn et al., 1940). Since then, both sporadic 
cases in humans and horses as well as major outbreaks have been reported in many 
countries of the Old World (Bernkopf et al., 1953; Hubálek et al., 1999; Murgue et al., 
2001 a; Murgue et al., 2002). This includes a series of WNV outbreaks that occurred 
in several countries in southern/eastern Europe, Russia and around the 
Mediterranean basin during the last three decades (Calistri et al., 2010). Many 
ecologic aspects of WNV infection, involving mosquitoes, birds, and humans, have 
been well documented since the early 1950s in Egypt (Taylor et al., 1956), in the 
1960s in the Camargue, southern France (Joubert et al., 1970), and in the 1970s in 
South Africa (McIntosh et al., 1976). By far the largest outbreaks in Europe occurred 
in Bucharest, Romania, in 1996 (393 human cases; 17 deaths) and Volgograd, 
Russia, in 1999 (826 human cases; 40 deaths). Both outbreaks happened in urban 
areas and were associated with cellars flooded with sewage-polluted water in poorly 
maintained apartment blocks, resulting in optimal breeding sites for Culex pipiens 
(Tsai et al., 1998; Platonov et al., 2001). Despite the fact that WNV circulation has 
been known in Europe for many decades, awareness of the disease increased with 
the introduction of WNV to the US in 1999 (Nash et al., 2001) and its tremendous 
spread from the East to the West Coast within only five years (Debiasi and Tyler, 
2006). To date, WNV is widely established in the Americas being the leading cause 
of arboviral encephalitis in the US with 12,447 cases of encephalitis and meningitis, 
and 1,185 deaths reported in humans (data: CDC, 1999–present). The majority of the 
strains responsible for the outbreaks in Europe and the US belong to lineage I and 
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are grouped into two different clusters which might have an important impact on the 
strain pathogenicity (Lanciotti et al., 2002; Charrel et al., 2003). Strains belonging to 
the European Mediterranean/Kenyan cluster are characterized by a moderate 
pathogenicity for horses and humans and limited or no pathogenicity for birds. In 
contrast, strains grouped in the Israeli/American cluster are characterized by high 
rates of avian deaths and, in the US, also by high rates of illness and death in 
humans and horses (Komar et al., 2001; Schuffenecker et al., 2005). Compared to 
the US situation, the incidence of WNV in Europe is poorly studied and the risk of a 
similar epidemic, although low, cannot be precisely estimated. However, following the 
large urban outbreaks in Bucharest and Volgograd, further evidence of WNV 
transmission has been identified in humans and/or horses in the last years: in the 
Czech Republic (1997), in France (2000, 2003, 2004, 2006), in Italy (1998, 2008–
2009), in Hungary (2003–2008), in Romania (1997–2000, 2008–2009), in Spain 
(2004), and in Portugal (2004) (Hubálek et al., 1999; Ceianu et al., 2001; Murgue et 
al., 2001 b; Connell et al., 2004; Del Giudice et al., 2004; Jourdain et al., 2007; 
Kaptoul et al., 2007; Krisztalovics et al., 2008; Macini et al., 2008; Popovici et al., 
2008; Alonso-Padilla et al., 2009; Rizzo et al., 2009; Sotelo et al., 2009; Angelini et 
al., 2010). Figure 1 shows the areas in Europe and in the Mediterranean basin where 
WNV transmission occurred since 1962. More recently, in 2009, human cases of 
WNV infection were reported from Hungary (7 cases), Romania (2 cases) and Italy 
(16 cases). In July 2010, Portugal reported a probable case of WNV infection which 
was the first (probable) case of WNV infection reported in the European Union (EU) 
in 2010 (ECDC, 2010). WNV-specific titers for IgM and IgG between two paired 
samples suggested a recent infection with WNV, but confirmatory tests by 
neutralization conducted in the Robert Koch Institute (RKI), Germany, were negative. 
Since July 2010, the WHO Regional Office for Europe, together with key partners – 
such as the European Centre for Disease Prevention and Control (ECDC), the 
ENIVD, and the EpiSouth network for communicable disease control in Southern 
Europe and Mediterranean countries – has been closely monitoring the regional 
situation of WNV due to a number of reports of neuroinvasive disease. As of early 
September 2010, over 600 cases of human WNV disease have been officially or 
unofficially reported from Greece, Hungary, Israel, Italy, Portugal, Romania, Russia, 
and Turkey. After the recorded outbreak of WNV infection in humans in Bucharest in 
1996, this is the second largest outbreak of the disease in the EU. The current 
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outbreak shows very well that WNV circulation is a fact in several countries of the EU 
and beyond, with new areas of transmission identified in Romania and Italy, and for 
the first time in Greece and Turkey. Furthermore, lineage II WNV seemed to be 
involved in this outbreak, which commonly has not been identified in humans or 
horses in the EU. 
 
I.2.2 Toscana virus  
TOSV belongs to the genus Phlebovirus within the family Bunyaviridae. This genus 
currently comprises 68 antigenically distinct serotypes and contains the majority of 
known sandfly-borne viruses (Liu et al., 2003; Depaquit et al., 2010). Phleboviruses 
have been isolated in the Americas from sandflies belonging to the genus Lutzomyia, 
and in Africa, Southern Europe, and Central Asia mainly from Phlebotomus and also 
from Sergentomyia (Brett-Major and Claborn, 2009; Depaquit et al., 2010). However, 
mosquitoes and ticks can also transmit phleboviruses (Elliott et al., 2000; Chevalier 
et al., 2010; Stone, 2010). Eight phleboviruses (Alenquer virus, Candiru virus, 
Chagres virus, sandfly fever Naples virus, Punta Toro virus, Rift Valley fever virus, 
sandfly fever Sicilian virus, and sandfly fever Toscana virus) have been linked to 
diseases in humans of which in Europe only TOSV, sandfly fever Naples, and Sicilian 
viruses are of importance. While the last two ones cause a febrile illness, TOSV is 
characterized by its neurotropism and the clinical characteristics of meningitis, 
meningoencephalitis, and flu-like disease (Charrel et al., 2005). The sandfly fever 
viruses (SFV) are widely distributed in the Mediterranean basin by several 
phlebotomine sandfly species as their main vectors and reservoirs (P. papatasi, P. 
perniciosus, P. ariasi, P. perfiliewi, and P. neglectus). There is evidence of the 
presence of different viruses within the same sandfly population. As animal reservoirs 
have not been confirmed until today, it is suggested that these viruses are 
maintained in their arthropod vectors by transovarial transmission and that vertebrate 
hosts play little or no role in the maintenance of these pathogens in the natural life 
cycle (Tesh, 1988). This could be underlined by presence of TOSV in wild-caught 
phlebotomine males (which do not take blood meals), demonstration of vertical 
transmission under laboratory conditions, and detection of venereal transmission 
from infected males to uninfected females (Tesh and Modi, 1984; Ciufolini et al., 
1989; Tesh et al., 1992). However, experimental evidence suggests that an 
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amplifying vertebrate host is needed to sustain the viruses in the arthropod 
populations (Ciufolini et al., 1985; Tesh and Modi, 1987; Ciufolini et al., 1989).  
In 2008, the 100th anniversary was celebrated of an Austrian expedition sent to 
characterize ‘Pappatacifieber’ in the Balkans (Doerr and Taussig, 1909; Flamm, 
2008). Even though pappataci fever (also known as three-day fever, sandfly fever, 
dengue Mediterranean, evil dog “Hundskrankheit”, and phlebotomus fever) was first 
described clinically by Pick in 1886, and the first manuscript on phlebotomine 
sandflies by Pym dates back to 1804, Doerr and his colleagues understood much of 
what is known today about sandfly fever (Dionisio et al., 2003). Interest in this 
disease increased and virus isolation (SFV Naples and Sicilian) happened during 
World War II as large numbers of troops serving in the Mediterranean basin suffered 
a flu-like, incapacitating illness well known to the locals (Sabin et al., 1944). 
Seroepidemiological studies have shown that the prevalence of antibodies against 
SFV Naples and Sicilian is more than 50%, especially in Mediterranean countries 
(Tesh et al., 1976; Nicoletti et al., 1996). However, there are only a few reports of 
clinical cases among the native population and some virus isolation from sandflies, 
and human cases have often been found in people visiting Mediterranean countries 
(Filipe, 1974; Saidi et al., 1977; Niklasson and Eitrem, 1985; Darwish et al., 1987; 
Eitrem et al., 1991 a; Eitrem et al., 1991 b; Cohen et al., 1999; Batieha et al., 2000; 
Mehrabi Tavana, 2001; Dionisio et al., 2003; Papa et al., 2006; Konstantinou et al., 
2007; Izri et al., 2008). Recent research interest in sandfly fever has increased 
because of outbreaks of acute meningitis/meningoencephalitis in several European 
countries bordering the Mediterranean Sea and cases of severe neurologic disease 
in European travelers linked to TOSV (Mendoza-Montero et al., 1998; Valassina et 
al., 2000; Dionisio et al., 2001; Echevarría et al., 2003; Hemmersbach-Miller et al., 
2004; Navarro et al., 2004; Charrel et al., 2005; Defuentes et al., 2005; Di Nicuolo et 
al., 2005; Kuhn et al., 2005; Peyrefitte et al., 2005; Sanbonmatsu-Gámez et al., 2005; 
Charrel et al., 2007; De Lamballerie et al., 2007; Santos et al., 2007; Sanbonmatsu-
Gámez et al., 2009; Sonderegger et al., 2009; Gabriel et al., 2010). Based on these 
studies and case reports, TOSV is circulating not only in Italy (where it was first 
isolated in 1971) but also in Portugal, Spain, France, Greece, Cyprus, and Turkey. 
Furthermore, in Italy (Francisci et al., 2003; Valassina et al., 2003; Pugliese et al., 
2007 b), in southeastern France (De Lamballerie et al., 2007), and in Spain 
(Mendoza-Montero et al., 1998; Echevarría et al., 2003; Sanbonmatsu-Gámez et al., 
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2005) seroprevalence studies were conducted, with prevalences ranging from 3% (in 
Northern Italy) up to 26% (in Southern Spain). TOSV must be considered as an 
emerging pathogen in the Mediterranean basin and therefore a significant public 
health issue in Europe (Charrel et al., 2005). Current data regarding the distribution 
of sandfly fever viruses and their main vectors in the EU and neighboring countries 
around the Mediterranean Sea can be obtained from the VBORNET-project of the 
ECDC. Due to the fact that sandflies are typical Mediterranean faunal elements that 
do not spread widely, any occurrence of phlebovirus infections was restricted to 
southern parts of Europe until recently. Since 1999, sandflies have been found in 
Central Europe north of the Alps, and so the introduction and establishment of certain 
sandfly-borne pathogens like TOSV or SFV Naples and Sicilian in biological cycles 
inside temperate regions can no longer be excluded  (Aspöck et al., 2008; Depaquit 
et al., 2010). Finally, new phleboviruses of unclear pathogenicity, such as the 
Granada virus, that circulate among phlebotomine sandflies may cause infections in 
Europe (Collao et al., 2010), and highly pathogenic phleboviruses like Rift Valley 
fever virus may be introduced to Europe (Chevalier et al., 2010). 
 
I.2.3 Tick-borne encephalitis virus 
TBEV is a medically important member of the genus Flavivirus, family Flaviviridae 
(Thiel et al., 2005). It is classified as one species with three subtypes, namely the 
European subtype, the Siberian subtype, and the Far Eastern subtype, which are 
associated with varying degrees of disease severity (R žek et al., 2010). Besides 
TBEV, three other tick-borne flaviviruses, i.e. Louping ill virus, Langat virus, and 
Powassan virus, also trigger encephalitis in mammals, but these infections occur 
infrequently and the viruses do not cause significant outbreaks (Gritsun et al., 2003 
a; Charrel et al., 2004; Lindquist and Vapalahti, 2008; Mansfield et al., 2009; Dobler, 
2010). The principal vector as well as reservoir of the European TBEV subtype is 
Ixodes ricinus, and I. persulcatus for the other two subtypes (Rampas and Gallia, 
1949; Gritsun et al., 2003 b; Süss, 2003; Golovljova et al., 2004). Although the virus 
has been isolated from several other tick species (Gresíková and Noseck, 1966; 
K ivanec et al., 1988; Zlobin and Gorin, 1996; Gresíková and Kaluzová, 1997; 
Gritsun et al., 2003 a), in nature only the two ixodid tick species mentioned appear to 
play an important role in virus maintenance and contribute significantly to the 
epidemiology of human disease (Pavlovskij, 1939; Labuda and Randolph, 1999). 
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Horizontal TBEV transmission between ticks and their vertebrate reservoir hosts is 
necessary for virus endemism (Nuttall and Labuda, 2003). The duration of viremia in 
hosts is crucial for TBEV transmission to ticks, because the virus is mostly ingested 
by ticks at the moment while engorging on a viremic host. Generally, the hosts are 
divided into three groups: reservoir, indicator, and accidental hosts (Charrel et al., 
2004). Natural reservoir hosts of TBEV, i.e. animals that are sensitive to the virus, 
exhibiting viremia for long periods of time without becoming clinically ill and thus 
important for the transmission of the virus to ticks, include rodents (Clethrionomys, 
Apodemus, Mus, Microtus, Micromys, Pitymys, Arvicola, Glis, Sciurus, and Citellus) 
(Kozuch et al., 1967), insectivores (Sorex, Talpa, Erinaceus) (Kozuch et al., 1967), 
and carnivores (Vulpes, Mustela) (Karabatsos, 1985; Süss, 2003). Insectivores and 
rodents also harbor the virus during the winter. Indicator hosts are unable to transmit 
the virus to other vectors, either due to only brief viremia with low virus production, or 
due to lack of necessary cell-based mechanisms to support non-viremic transmission 
during co-feeding (Labuda et al., 1996). Accidental hosts of TBEV are humans who 
can be infected by a bite of an infected tick, or by consumption of non-pasteurized 
milk from viremic livestock, as well as large animals such as goats, cows, sheep, roe 
deer, dogs, and swine. They can develop a disease with viremia, but they do not 
participate in virus circulation in nature and are, therefore, a dead end of the natural 
TBEV cycle (Fig. 2). In addition, seroprevalence in these large vertebrates may 
represent an indirect means of measuring the intensity of TBEV transmission within a 
geographical region and make them valuable sentinels for epidemiological risk 
assessment (Gritsun et al., 2003 a; Donoso Mantke et al., 2008 b).  
 
Although the first hints of the existence of the disease date back to Scandinavian 
church records from the 18th century (Åland islands, Finland), what is known today as 
tick-borne encephalitis (TBE) was first recognized and medically described by the 
Austrian physician H. Schneider in 1931 as ‘meningitis serosa epidemica’ of 
unknown etiology (Schneider, 1931). A disease with similar clinical symptoms had 
been observed in the Far East since 1914, but has occurred more frequently since 
1933, and shortly thereafter – during three successive expeditions in 1937–1939 – 
the etiologic agent was isolated in Russia and its transmission by ticks could also be 
demonstrated (Zilber, 1939). The disease was called ‘Russian spring–summer 
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encephalitis’ (or Far East or taiga encephalitis), and the virus became known as 
Russian spring–summer encephalitis virus and lately TBEV. In Finland, TBE was 
initially described as ‘Kumlinge disease’ in the 1940s (Oker-Blom, 1956), and the first 
European TBEV was isolated in Czechoslovakia after the Second World War in 1948 
(Gallia et al., 1949; Krej í, 1949 a), when the incidence of clinical manifestations 
caused by the virus was so high that it was noticed by infectiologists in affected 
regions (Krej í, 1949 b). Simultaneously, the virus was also isolated from I. ricinus, 
suggesting the role of the tick as a vector of the disease (Rampas and Gallia, 1949). 
Today, the distribution of TBEV correlates with the ixodid tick vectors’ occurrence 
(Fig. 2). I. ricinus occurs in most parts of Europe, and the distribution extends to the 
southeast (Turkey, Northern Iran, and Caucasus) (Nuttall and Labuda, 1998). I.
persulcatus is seen in the vast area extending from Eastern Europe to China and 
Japan (Jaenson et al., 1994). Parallel occurrence of both tick species was reported in 
northeastern Europe and the east of Estonia and Latvia, as well as in several 
European regions of Russia (Haglund et al., 2003; Bormane et al., 2004; Golovljova 
et al., 2004; Jääskeläinen et al., 2006 a). The prevalence of TBEV-infected I. ricinus 
ticks varies from 0.5% to 5%, whereas in I. persulcatus in certain regions of Russia 
prevalence up to 40% was recorded (Charrel et al., 2004). It should be noted that 
methods for measuring virus prevalence in ticks or animal reservoirs have not been 
standardized, and reliable tools should be introduced to translate epizootic 
prevalence data into infection risk for humans. However, TBE occurs in many parts of 
Central Europe and Scandinavia, particularly in Austria, the Czech Republic, Estonia, 
Finland, Germany, Hungary, Latvia, Lithuania, Poland, Russia, the Slovak Republic, 
Slovenia, Sweden, Switzerland, and also Northern Asia (Bröker, 2008; Donoso 





























Figure 2 Life cycle and distribution of ixodid ticks and TBEV 
Upper panel: The life cycle of ixodid ticks consists of three developmental stages (larva, nymph, and adult). Each stage needs 
to take a blood meal on a suitable vertebrate host, usually for a period of a few days, to develop into the next stage. Further, 
adult female ticks need a blood meal for egg production. Each stage of I. ricinus takes approximately one year to develop into 
the next stage. Thus, it takes 3 years on average for the completion of the shortest life cycle. TBEV infects ticks chronically for 
the duration of their life while feeding on infected animal reservoir hosts. It can be transmitted transstadially (from one stage to a 
subsequent one), transovarially, or primarily from nymphs to naïve larvae while co-feeding on the same rodent host. TBEV can 
be transmitted to man or other animal hosts by all three tick stages with different prevalence. Lower panel: Different shadings 
show the western distribution of I. ricinus and eastern distribution of I. persulcatus. The distribution of both vectors overlaps in 
the checkered area. The dotted line shows the border of the TBE-endemic area. Note that TBE is distributed in an endemic 






The number of human cases of TBE in all endemic regions of Europe has increased 
by almost 400% in the last 30 years. In 2006, 3,914 cases were reported in Europe 
when excluding Russia (7,424 cases when including Russia), the highest number 
since 1995 (Kunze et al., 2010). It is important to note that fluctuations are a typical 
phenomenon in the TBE epidemiology which depend on various factors, e.g. weather 
and climate, rodent prevalence, or human behavior. Furthermore, new TBE foci are 
emerging and latent ones re-emerging in several European countries (Bröker and 
Gniel, 2003; Donoso Mantke et al., 2008 b; D'Agaro et al., 2009; Fomsgaard et al., 
2009; Ergünay et al., 2010). In Russia, the highest TBE incidence is reported in 
Western Siberia and Ural (Gresíková and Kaluzová, 1997). No TBE cases have been 
reported in e.g. Great Britain, Ireland, Iceland, Belgium, the Netherlands, Luxemburg, 
Spain, and Portugal. In contrast, Bulgaria, Croatia, Denmark, France, Greece, Italy, 
Norway, Romania, Serbia, China, and Japan are countries with only sporadic TBE 
occurrence. Because of the increased mobility of people travelling to risk areas, TBE 
has become an international public health problem with relation to travel medicine. 
The risk of an infection is especially high for people living in endemic areas or visiting 
them for leisure activities in nature (Bröker and Gniel, 2003). Recently, the ECDC 
launched an internet-based spotlight on tick-borne diseases including fact sheets and 
relevant information on TBE.   
 
I.3 Diagnostics of arboviruses 
 
I.3.1 Clinical diagnosis 
After suspecting viral encephalitis, the approach to clarify the etiology of the disease 
should consist of obtaining a meticulous history of the patient and of a careful general 
and neurological examination (Steiner et al., 2010). Early diagnosis is vital, as 
symptoms can appear suddenly and escalate to brain damage, hearing and/or 
speech loss, blindness, or even death. The history is mandatory in the assessment of 
the patient. Therefore, it could be important to obtain relevant information from an 
accompanying person (relative, friend, etc.) if the patient is in a confused, agitated, or 
disoriented state. To consider an arboviral etiology, the patient’s history should 
include questions related to the geographical location of exposure and recent travel 
history (to identify endemic/regionally prevalent pathogens); seasonal occurrence 
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(summer–fall, rainy season); occupation and outdoor activities (forestry worker, 
farmer, camping, hiking, etc.); contact with wild or domestic animals (e.g. birds’ 
feces); history of arthropod bite (e.g. tick bite); and mode of the course of disease up 
to the appearance of the neurological signs (like bleeding tendency outside the CNS, 
indicating viral hemorrhagic fever). Viral infection of the CNS is almost always part of 
a generalized systemic infectious disease. Thus, other organs may be involved prior 
to or in association with the CNS manifestations, as described e.g. for TBE and West 
Nile disease (Misi -Majerus et al., 2005; Gyure, 2009). A neurological examination 
involves a series of tests designed to assess motor and sensory function, nerve 
function, hearing and speech, vision, coordination and balance, mental status, and 
changes in mood or behavior. Neuroimaging can reveal signs of brain inflammation, 
internal bleeding or hemorrhage, or other brain abnormalities. The findings relate to 
those of meningitis and disruption of brain parenchyma function. An 
electroencephalogram (EEG) may help demonstrate cerebral involvement during the 
early stage of disease. Only in rare instances does the EEG show specific features 
that may give clues to the diagnosis (e.g. HSE). Magnetic resonance imaging (MRI) 
is a more sensitive and specific application than computerized tomography (CT) 
when evaluating viral encephalitis. However, in practice these methods are of little 
help in the differential diagnosis. 
 
I.3.2 Laboratory diagnosis 
Examination of peripheral blood and/or CSF (incl. cell count and cellular morphology) 
gives a first conclusive clue to the nature of disease. A lymphocytosis in peripheral 
blood or lymphocytic pleocytosis in CSF with elevated protein and normal glucose 
levels are non-specific findings in viral encephalitis, and separate from other infective 
non-viral forms of meningitis or encephalitis (Debiasi and Tyler, 2004; Steiner et al., 
2010). Ultimately, in a patient with suspected viral encephalitis the core diagnostics 
of choice is to obtain serum and CSF for virological tests. Diagnostic testing for 
arboviruses is mainly limited to patients who are suspected to be infected by these 
viruses based on the patients’ history. Different measures for virus diagnosis can be 
initiated to confirm the clinical diagnosis. During acute infection, it is only possible to 
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Figure 3 Schema for diagnosis of viral infections 
 
For particle detection by electron microscopy, virus loads have to exceed 106/mL, 
which is largely dependent on the virus, the course of infection, and the time point of 
investigation. Table 3 gives a brief overview on the sensitivity and specificity of the 
different diagnostic methods. The estimated time required for the different diagnostic 
assays also gives important information on the practicality of these methods in the 
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Table 3 Basic features of different diagnostic methods*
Method Time for diagnosis Sensitivity Specificity
Virus detection
Virus isolation 1-7 days Higha Highb
Hybridization 3-4 hr Highc Good
PCR 2-4 hr Highd High
Pyrosequencing 1 hr Highe High
Electron microscopy 30 min Lowf Highg
Capture ELISA 3-5 hr Goodh High
Serology
ELISA 3-4 hr High Low
Immunofluorescence 2-4 hr Good Good
Immunoblot 2-4 hr Good Good
Neutralization 4-7 days Good High
HIA 2-4 hr Low Good
* Adapted from Niedrig et al., book chapter in press.
a Depending on cultivation system
b Depending on detection system
c ca. 104 particle/mL
d ca. 200 genome equivalent/mL
e Requires PCR
f 106 particle/mL  
g Detection of the virus family

















Because of the low commercial impact of most of the arboviruses, there are no 
specific assays for protein detection, but some assays are available as in-house 
assays in only a few laboratories (Table 4). Some assays may involve 
immunohistochemical staining of tissue samples with monoclonal antibodies directed 
against the suspected virus (Bae et al., 2005). Other assays applied for the detection 
of virus antigens are specific capture enzyme immunoassays (EIA), but these are 
rather uncommon and not very sensitive. Owing to the unique genetic code of RNA 
and DNA, the detection of virus-specific sequences by PCR methods has been the 
major technology for diagnostic testing for many years. In general, PCR approaches 
are very rapid, enable extremely low detection limits, and provide genetic material for 
further characterization (e.g. by sequencing). On the other hand, the high specificity 
due to the exact base pairing of primer and template may lead to false-negative 
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results even after minor changes in the target sequence. Since flaviviruses are prone 
to frequent sequence aberrations the PCR assays used should be selected carefully. 
Finally, the exact target virus sequences have to be available for the proper design of 
reliable assays, a prerequisite that is hard to achieve for flaviviruses. However, nearly 
all recent cases of acute viral hemorrhagic fevers imported to the Western World 
were diagnosed by PCR, before a confirmation by virus cultivation was performed 
successfully. Virus cultivation on suitable cells is an additional option for virus 
detection in an acute phase of disease. Cultivation is laborious and can take one to 
seven days depending on the susceptible cells used and the amount of virus in the 
patient’s serum. However, a specific method for the unequivocal identification of 
samples showing even typical cytopathic effects is essential. Since nearly all of these 
viruses (except for the sandfly fever viruses) are highly pathogenic and have to be 
handled in a high containment laboratory, virus cultivation is limited to a few highly 
experienced facilities. 
The introduction of WNV into North America in 1999 as a new pathogen caused 
serious problems, including the initial misdiagnosis as St. Louis encephalitis (SLE). 
Up to then SLE had been a common infection in the US, caused by SLEV, a virus 
also belonging to the Flaviviridae with high potential for cross-reactivity in other 
serological flavivirus assays. It turned out very soon that WNV easily spreads by 
infected migrating birds and can also occasionally be transmitted to humans by 
infected mosquito vectors. This newly emerging infection made it necessary to 
develop diagnostic tools for detecting WNV in acute encephalitis patients and for 
providing safe blood and plasma for medical care. Accidental transmission by 
transplanting organs of an infected donor clearly showed that reliable diagnostic 
assays are required to meet established biological safety standards (Iwamoto et al., 
2003). Tremendous efforts were made by introducing routine screening of blood and 
blood products by EIA and RT-PCR to avoid any further transmission. Such a routine 
testing is always based on evaluated and standardized diagnostic assays. However, 
the use of certified EIAs does not overcome the general problem of cross-reactivity 
among the flaviviruses. As found in evaluation studies for different commercially 
available EIAs for WNV-specific IgG, all of them also showed positive reactivity with 
anti-YF and anti-TBE sera (Malan et al., 2004; Pfleiderer et al., 2006; Linke et al., 
2008). Even when applying the plaque reduction neutralization technique usually 
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Table 4 Overview of the most used diagnostic methods for selected arbovirus infections*
Acute/early phase Acute/late phase Convalescent phase
PCRa,b, VIb, IH, IgM/IgG EIAa,
EIAa (NS-1) IgM/IgG IFAa




Tick-borne encephalitis virus PCRb, VIb, IH IgM EIAa, IFAa, HIA IgM/IgG EIAa, IgM/IgG 
IFAa, HIA
Chikungunya virus PCRb, VIb, IH IgM/IgG EIA, IgM 
IFAa, HIA
IgM/IgG IFAa, HIA
Sandfly fever virus PCRa,b, VIb IBa, IgM IFAa IBa, IgM IFAa, IgM/IgG 
EIAa
Crimean Congo hemorrhagic fever virus PCRb, VIb IgM/IgG EIAa, IgM 
IFA
IgM/IgG EIA, IgG IFA
Rift Valley fever virus PCRb, VIb IgM/IgG EIAa, IgM 
IFA,  HIA, inhibition 
EIA
IgM/IgG EIA, IgG IFA, 
HIA
* Adapted from Niedrig et al., book chapter in press.
a Commercial assays available.
b Methods useful for analysis of enviromental or vector (mosquitoes, ticks, phlebotomes) samples.
Abbreviations:
EIA- Enzyme immunoassay; HIA- Hemagglutination inhibition assay; IB- immunoblot; IFA- immunofluorescence 
assay; IH- Immunohistological analysis of tissue samples; PCR- Polymerase chain reaction; VI- Virus isolation 
on cells.




IgM EIAa, IFAa, HIA, 
rapid tests
Dengue virus 1-4
West Nile virus PCRa,b, VIb, IH
providing the highest specificity, certain high-titer sera displaying anti-YF and/or anti-
TBE reactivity showed cross-neutralization activity to WNV as well.  
 
 
In an external quality assurance (EQA) for the serological detection of WNV-positive 
sera, it turned out that only 8/27 (29.6%) of the participating laboratories reached the 
proficiency criteria for correct IgM and IgG detection. These data demonstrate the 
challenge to achieve a reliable serological diagnosis of WNV infection (Niedrig et al., 
2007 a). To overcome these cross-reactivity problems, the analysis of antibody 
avidity might be a rapid and simple option. As shown for differentiation of primary 
from previous WNV infection, the IgG avidity assay provides an additional diagnostic 
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certainty (Levett et al., 2005). This also needs to be evaluated for cross-reactivity 
with other flavivirus-reactive sera. A reverse ELISA based on the B domain of the E-
protein seems to be more specific (Ludolfs et al., 2007). With this assay it was 
possible to avoid the frequent cross-reaction caused by sera directed against other 
flaviviruses. For the diagnosis of WNV by PCR, several assays have been published 
(Lanciotti and Kerst, 2001; Linke et al., 2007). By epidemiological studies it could be 
shown that the two lineages found in Africa have a very distinct pattern of distribution 
(Campbell et al., 2002). In the US, due to the exclusive introduction of one virus 
strain, only variants of lineage 1 originally deriving from an Israeli prototype are 
present (Lanciotti et al., 1999; Hayes, 2001). The introduction of WNV lineage 2 into 
Hungary, Russia, Austria, and Greece was demonstrated recently (Bakonyi et al., 
2006; Erdélyi et al., 2007; Platonov et al., 2008; ECDC, 2010). This information has 
immediate consequences for the design of WNV-specific RT-PCR systems to be 
used in Europe, which should react with sequences of both lineages. As shown in an 
EQA, only 11/30 (36.7%) laboratories were able to detect lineage 2 in high 
concentration, which demonstrates the necessity for improving the other assays by 
adaptation of primers to lineage 2 of WNV (Niedrig et al., 2006).  
The SFV transmitted by phlebotomine flies is widely distributed in all countries of the 
Mediterranean region. The sandfly fever group comprises several different strains 
named after the regions where they were first isolated during local outbreaks: 
Toscana, Naples, Sicily, Corfu, and Cyprus (Xu et al., 2007). While the sandfly fever 
normally takes a very mild and aseptic course, meningitis and meningoencephalitis 
are rare complications due to TOSV. The number of reported infections is rather low 
(De Lamballerie et al., 2007). However, in recent years several studies demonstrated 
the presence of TOSV in Italy, Portugal, Spain, France, Greece, Cyprus, and Turkey, 
thus underlining the importance of the infectious agent (Hemmersbach-Miller et al., 
2004; Charrel et al., 2005; Sanbonmatsu-Gámez et al., 2005; Santos et al., 2007). 
Most of the diagnoses were performed by in-house assays, although commercial 
assays for serology such as EIA, IFA, and IB are available (see Table 4). The 
recently developed RT-PCRs for virus genome detection support the commercially 
available nested PCR assay and can be used for screening of phlebotomine flies as 
well as for analysis of patient specimens in acute infection (Pérez-Ruiz et al., 2007; 
Weidmann et al., 2008). The introduction of new and more sensitive PCR-based 
30 
tools will help improve the diagnosis of viral meningitis patients in sandfly-endemic 
areas. Seroneutralization assays using early convalescent sera remain the reference 
method used to specifically identify the sandfly fever viruses or to assess the 
antibody response specificity. Reference tools, reagents, and quality control are not 
widely available. However, the ENIVD is able to provide some of these reagents.    
TBE is the most important flavivirus infection in Europe and Russia, transmitted by 
infected ixodid ticks. The highest incidence is found in the area of Kemerovo in 
Siberia but ticks are also present in Central and Eastern Europe, with high 
prevalences causing a large number of encephalitis cases (Charrel et al., 2004; 
Korenberg and Likhacheva, 2006). The biphasic course of the disease caused by 
European strains starts with uncharacteristic influenza-like symptoms, followed by a 
symptom-free interval before a second phase with neurological symptoms develops 
in about 20–30% of the patients, with an occasionally fatal outcome (<2%) (Heyman 
et al., 2010). Very often the patients do not recognize or remember a tick bite which 
results in a late diagnosis for the patient. Serology is the most frequently used 
diagnostic approach in suspected cases, although some retrospective studies have 
shown that the TBEV could be detected by PCR in the early phase of the disease 
(Saksida et al., 2005; Donoso Mantke et al., 2007 b; Schultze et al., 2007). In the 
majority of cases, the first-line diagnosis is performed by testing for IgM using 
commercial TBE EIAs available from different manufacturers with reasonable quality. 
Although these EIAs cannot overcome the problem of serological cross-reactivity 
between the different flaviviruses, their quality improved after an extensive assay 
evaluation some years ago (Niedrig et al., 2001). In an EQA study for TBE serology, 
it turned out that correct results were obtained for at least 90% of the samples by 
33/40 (82.5%) participating laboratories for IgM and 16/42 (38.1%) laboratories for 
IgG, with testing often based on commercial EIAs (Niedrig et al., 2007 b). In contrast, 
it was shown that only 35–44% of the laboratories correctly detected the Far Eastern 
and/or the Siberian TBEV subtypes with PCR (Donoso Mantke et al., 2007 c), 
despite the fact that these subtypes are already present in northeastern Europe and 
the Baltic countries (Golovljova et al., 2004; Jääskeläinen et al., 2006 a; Donoso 
Mantke et al., 2008 b). For the first time R žek et al. have developed a multiplex RT-
PCR that is able to discriminate among all three TBEV subtypes (R žek et al., 2007). 
Recently, a further development of molecular diagnostic assays for TBEV now brings 
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together the advantages of quantitative real-time PCR (improved rapidity, sensitivity, 
reproducibility, reduced risk of cross-contamination) and the advantage of multiplex 
PCR (discrimination of different amplicons within a single reaction). This new PCR 
method is based on highly degenerated primers and probe targeting the NS1 protein 
region in a one-step assay and is followed by pyrosequencing (Achazi et al., 2010). 
Pyrosequencing is a new technique in which the enzymatic incorporation of the four 
different nucleotides, which are added separately and are complementary to the 
sequenced DNA strand, is monitored in real-time. For each incorporated nucleotide, 
a clear light signal is generated and presented as a peak histogram, called a 
pyrogram. Pyrosequencing has its strength in the sequencing of fragments of up to 
80 bases and the identification of single nucleotide polymorphisms (SNPs). It can be 
speculated that with the increasing requirement of diagnosing suspected acute TBEV 
infections, rapid diagnosis by PCR will become more important for the analysis of 
serum and/or liquor specimens. Unfortunately, because of the short viremia, a 
negative PCR result does not rule out a TBEV infection with certainty (Donoso 
Mantke et al., 2007 b). One argument for physicians not requesting PCR testing is 
that no specific medical treatment is available for TBE patients. However, this will 
hopefully change. Nevertheless, often other medical products such as antibiotics are 
given which might additionally be harmful for the patient.  
 
I.4 Surveillance of arbovirus encephalitis 
 
Despite improvements in the diagnosis of viral encephalitis, including CSF-PCR 
(Debiasi and Tyler, 2004; Romero and Newland, 2006; Steiner et al., 2010), the 
etiology of up to 85% of acute encephalitis cases has remained unknown in recent 
epidemiological surveys (Granerod and Crowcroft, 2007; Donoso Mantke et al., 2008 
a; Jmor et al., 2008; Mailles and Stahl, 2009). This issue is challenging, especially 
when considering the early detection of new and (re-) emerging pathogens such as 
WNV, TOSV, and TBEV (Pugliese et al., 2007 a; Vorou et al., 2007; Depaquit et al., 
2010; ECDC, 2010; Kunze et al., 2010), or potential outbreaks caused by a 
deliberate release of pathogens (Bossi et al., 2004). An accurate etiological diagnosis 
is important for surveillance activities aimed at clarifying the etiological pattern of viral 
encephalitis/meningitis. However, this is impossible to achieve as long as routine 
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clinical/laboratory investigations do not include the most common pathogens in a 
standardized manner. Moreover, a correct (differentiated) immediate diagnosis and 
the introduction of symptomatic or specific therapy may be of vital importance for the 
survival of patients and may reduce the extent of brain injury. 
Based on certain ENIVD activities and several European studies, data were obtained 
on the surveillance situation for viral encephalitis and meningitis in Europe, as well as 
on the possible etiologies in order to clarify the incidence and causes of viral 
encephalitis/meningitis at the national level (Donoso Mantke et al., 2008 a). It could 
be shown that comparative data for the incidence of most viral agents of human 
(meningo-) encephalitis are missing. In the presented studies, the proportion of cases 
with unknown etiology ranged between 30% and 80%. The reasons for unknown 
diagnosis could be traced to either a failure of the diagnostic tests or an inappropriate 
case definition, resulting in under-ascertainment of both known viruses and “new” 
viruses. Furthermore, the surveillance of emerging zoonotic diseases in European 
countries is not uniform. For example, although endemic in several countries, TBEV 
surveillance is not standardized concerning case definitions, laboratory diagnostic 
practice, and risk mapping, nor always mandatory in Europe (Donoso Mantke et al., 
2008 b). In order to increase the benefit of surveillance of acute encephalitis in 
Europe, it was developed that a broad standard case definition and 
harmonized/standardized diagnostic algorithm, using a multiplex-microarray system 
validated for a wide range of viruses, may help to discover the true incidence and 
etiological pattern of viral encephalitis/meningitis within each country. Currently it is 
still expensive to use microarrays that enable the detection of several microbes’ 
nucleic acids simultaneously, but they have the potential to become a useful 
diagnostic technique (Jokela et al., 2005; Jääskeläinen et al., 2006 b). This would 
offer a unique analysis platform for all participating laboratories in a European 
surveillance system for viral encephalitis/meningitis by including both the more 
common pathogens of viral CNS diseases (e.g. herpes simplex-, varicella-zoster-, 
enteroviruses) and relevant viral zoonotic agents (e.g. TBEV, WNV, rabies virus) 
according to the regional/endemic situation of the European countries or on special 
request. The proposed basis for a future surveillance system at the European level 
would guarantee high performance and comparability of the results consistent with 
EQA programs. The ENIVD has a huge expertise in organizing EQA studies for the 
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diagnostics of arboviruses, and has pointed out the importance of quality 
control/standardization of laboratory procedures for the detection, surveillance, and 
control of viral infections (Donoso Mantke et al., 2005; Niedrig et al., 2007 c). To 
improve surveillance, it is also important to quantify the extent of cases of unknown 
etiology in order to allow a comparison of the data from each country and to identify 
possible weaknesses in the surveillance data. Therefore, clinicians must be 
motivated to report all cases of viral encephalitis/meningitis and to reach a definitive 
etiological diagnosis. Some clinicians may not see confirmation as a priority, 
especially if in the clinical practice all suspected cases of acute encephalitis are 
routinely treated with acyclovir. 
Finally, the surveillance of clinical cases should be further backed up by vector 
surveillance (virological investigation of mosquitoes, ticks, flies, etc.) and indicator 
host surveillance (virological investigation/seroepidemiological surveys of humans, 
birds, horses, rodents, etc.) in order to expand and regularly update the knowledge 
about the circulation of certain arboviruses. This would facilitate the timely 
assessment of the risk for the exposed population and the application of public health 
measures in an optimal way. So far, such surveillance activities are not fully 
implemented in national surveillance systems for communicable diseases. And 
furthermore, methods to measure virus prevalence in vectors and animal hosts have 
not been standardized, and reliable tools should be introduced to translate epizootic 
prevalence data into infection risk for humans. A multidisciplinary approach is 
required involving professionals trained in human medicine, veterinary medicine, 
epidemiology, microbiology, parasitology, entomology, wildlife biology, and similar 
disciplines (Dufour et al., 2008; Stark et al., 2009). 
As one of the activities of the German Consultant Laboratory for Tick-borne 
encephalitis and further flaviviruses, we are working on the implementation of 
alternative indicators for risk assessment of tick-borne diseases in the national 
surveillance system. Therefore, in a pilot study we collected larvae, nymphs, and 
adult ticks in seven representative sampling sites around Berlin in a monthly planned 
routine from September 2008 to December 2009. Based on the collected ticks, the 
tick-density factor (TDF) for each area was estimated followed by the additional 
analysis of the presence of different tick-borne pathogens (Borrelia burgdorferi sensu 
lato, Rickettsia spp., Babesia spp., and Anaplasma spp.) in the collected ticks, using 
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new commercial assays for this purpose. The results provide valuable data for the 
estimation of the presence of ticks and the risk of infection by tick-borne pathogens in 
the Berlin area, where little is known about the distribution of tick species and the 
harbored pathogens (Hagedorn et al., 2010; submitted). In another study we 
investigated the suitability of rodents as a surrogate marker for virus spread. Here we 
could show that in experimentally infected Microtus arvalis voles TBEV was 
detectable in different organs for at least three months and in blood for one month. 
10% of all rodents analyzed were positive for TBEV. Therefore, we tested the 
suitability of rodents as sentinels for the virus prevalence in the field. Based on data 
from wild-caught rodents in several areas of Germany, we found that in TBE risk 
areas the infection rate of rodents was higher compared to that of areas with only 
single human cases or non-risk areas. TBEV was detected in six rodent species: 
Apodemus agrarius, A. flavicollis, A. sylvaticus, Microtus agrestis, M. arvalis, and 
Myodes glareolus. However, M. glareolus showed a high infection rate in all areas 
investigated (Achazi et al., 2010; submitted).  
 
I.5 Objectives of published studies 
 
The objectives of the published studies selected are all part of activities within the 
ENIVD network and/or the German Consultant Laboratory for Tick-borne encephalitis 
and further flaviviruses. These involve a preliminary survey regarding the 
epidemiological situation of viral encephalitis in EU Member States (also including a 
survey on TBE surveillance in Europe). The objectives are to identify the 
requirements for a possible future surveillance study at European level, as well as to 
improve the diagnostic methods and to carefully monitor the present situation 
especially regarding WNV, TOSV, and TBEV as potential emerging arboviral causes 
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Infekce mozku, míchy a mozkových plen p edstavují hlavní p í iny encefalitidy, 
myelitidy a meningitidy u lov ka. Nicmén  jisté procento t chto onemocn ní 
z stává bez ur ení etiologického p vodce z d vodu neschopnosti jej identifikovat.  
V tšina p ípad  encefalitidy je zap í in na virovou infekcí: virus herpes simplex, 
virus varicella-zoster, virus Epsteina a Barrové, virus p íušnic, virus spalni ek a 
enteroviry jsou pokládány za hlavní p vodce encefalitidy u imunokompetentních 
jedinc . Vedle t chto klinicky astých p ípad  mohou být p í inou encefalitidy i viry 
p enášené lenovci (komáry nebo klíš aty). Tyto infekce mohou být zam n ny 
nej ast ji za herpetické encefalitidy. V Evrop  jsou nejvýznamn jšími encefalitickými 
arboviry virus západního Nilu, virus Toscana a virus klíš ové encefalitidy.  
Zp sob, jakým evropské zem  provád jí monitoring a diagnostiku virových 
encefalitid, vykazuje zna nou variabilitu a tudíž data z r zných zemí nejsou 
porovnatelná. Navzdory pokrok m PCR diagnostiky virových encefalitid z stává 
etiologická p í ina až v 80% p ípad  neur ena. Význam tohoto problému nar stá 
díky pot eb  rychlé a spolehlivé detekce nových a (re-)emergentních patogen , jako 
je virus západního Nilu, i potenciálních epidemií zp sobených zám rným ší ením 
patogen . Kvalitní diagnostika je zcela kritická pro monitoring etiologických agens 
virových encefalitid/meningitid. Toho však nelze dosáhnout dokud nebudou 
nejb žn jší výše uvedení patogeny sou ástí rutinního testování. Krom  toho správná 
diagnostika a v asné zahájení odpovídající symptomatické nebo specifické terapie 
m že omezit poškození mozku infekcí a v kone ném d sledku rozhodnou o 
samotném výsledku onemocn ní. 
Evropská sí  pro diagnostiku importovaných virových onemocn ní (The European 
Network for Diagnostics of ‘Imported’ Viral Diseases - ENIVD) provedla n kolik studií 
za ú elem shrnutí dostupných dat a zlepšení jejich získávání a pro posílení 




požadavky pro budoucí monitorující studie na evropské úrovni a p isp la ke zlepšení 
kvality provád ných diagnostických metod zp sobem externího hodnocení kvality. 
Krom  toho d kladn  sledovala sou asnou situaci výskytu viru západního Nilu, viru 
Toscana a viru klíš ové encefalitidy, ili potenciálních emergentních p vodc  
virových encefalitid.  
ENIVD analyzovala sou asnou situaci monitoringu virových encefalitid a meningitid 
v Evrop , ímž shrnula dostupné zdroje epidemiologických dat u jednotlivých stát  
Evropské unie. Dála mapovala laboratorní kapacity a identifikovala klí ové 
požadavky pro budoucí studie zam ené na monitoring v evropském m ítku. 
Doporu ili a zavedli jsme široce platné definice onemocn ní a standardizovali 
diagnostické postupy. Jejich pomocí s využitím multiplex-microarray systém  
validovaných pro široké spektrum vir , bude možné odhalit skute nou incidenci a 
etiologický pattern virových encefalitid/meningitid v každé evropské zemi. Toto bude 
zaru ovat dobrou srovnatelnost výsledk , konzistentních se systémem externího 
hodnocení kvality. Pro zlepšení monitoringu je rovn ž d ležité kvantifikovat množství 
p ípad  nejasné/neznámé etiologie. Díky tomu bude snazší srovnávat data  
z jednotlivých zemí, p ípadn  ur it slabiny monitoringových program . Klini tí léka i 
musí být dostate n  motivováni hlásit všechny p ípady virových encefalitid/meningitid 
a snažit se vždy ur it p esnou etiologickou diagnózu. Evropská studie založená na 
t sné spolupráci klinických léka , epidemiolog  a mikrobiolog  poskytne p esn jší a 
asov  dostupn jší data o virových onemocn ních centrální nervové soustavy. 
Taková iniciativa by mohla napomoci zvýšení frekvence správné diagnózy, snížit 
množství p ípad  onemocn ní neznámé etiologie, vyvinout a validovat nové 
diagnostické metody, zlepšit doporu ení a návody, a celkov  vyt žit více hodnotná 
data z klinických a epidemiologických program .  
Studie externího hodnocení kvality provedené sítí ENVID ukázaly, že metody 
užívané ve v tšin  klinických laborato í fungují dob e p i použití virového 
prototypového kmene, jsou ale mén  spolehlivé v p ípad  užití recentn  se 
vyskytujících virových kmen /izolát . P íkladem budiž detekce nov  se objevujících 
kmen  viru západního Nilu, linie II, b žn  se vyskytujících v Africe, i detekce 
sibi ských nebo dálnovýchodních kmen  viru klíš ové encefalitidy. Výskyt kmen  viru 




Sibi ské a dálnovýchodní kmeny viru klíš ové encefalitidy se b žn  vyskytují 
v n kterých zemích Evropské unie, jako nap . v pobaltských republikách a Finsku. 
Výsledky externího hodnocení kvality p inesly p ehled o sou asných diagnostických 
možnostech evropských laborato í. Krom  toho byla laborato ím se slabšími 
výsledky nabídnuta pomoc a poskytnuty instrukce pro zvýšení kvality výsledku. 
V budoucnu bude existovat díky naším studiím lepší vhled do situace týkající se 
monitoringu virových encefalitid v Evrop .  
 
Summary 
Infectious processes in the brain, spinal cord, and meninges are considered to be the 
main causes of encephalitis, myelitis, and meningitis. However, a certain part of 
these neurological diseases remains without etiological diagnosis because of lack of 
understanding and/or use of unsuitable assays. 
Most cases of encephalitis are caused by viral infections: herpes simplex viruses, 
varicella-zoster virus, Epstein-Barr virus, mumps virus, measles virus, and 
enteroviruses are considered to be the major causes of viral encephalitis in immuno-
competent individuals. In addition to these clinically common pathogens, arthropod-
borne viruses (transmitted through the bite of insects and ticks) may cause arboviral 
encephalitis that can be confounded with herpes simplex encephalitis. In Europe, the 
most important types of arboviral pathogens causing encephalitis are West Nile virus 
(WNV), Toscana virus (TOSV), and tick-borne encephalitis virus (TBEV).  
The way in which European countries handle the surveillance and diagnostics of viral 
encephalitic diseases varies widely and, therefore, these issues are not comparable. 
Despite improvements in the PCR diagnosis of viral encephalitis, comprising analysis 
of cerebrospinal fluid, the etiology of up to 80% of encephalitis cases remained 
unknown in recent surveys. This issue is challenging when considering early 
detection of new and (re-) emerging pathogens such as WNV or potential outbreaks 
caused by deliberate release of pathogens. The reliable diagnosis is important for 
surveillance activities aimed at clarifying the etiological pattern of viral 




investigations do not include the most common pathogens (see above) in a 
standardized manner. Moreover, a correct (differentiated) immediate diagnosis and 
introduction of symptomatic or specific therapy may have a decisive influence on 
survival of patients, and may reduce the extent of brain injury.  
The European Network for Diagnostics of ‘Imported’ Viral Diseases (ENIVD) has 
completed studies in order to improve compiling and collecting data and to enhance 
the diagnostics and monitoring of encephalitis viruses in Europe. Our group has 
identified requirements for a future surveillance study at the European level and 
intended to improve diagnostic methods by external quality assurance (EQA). Also, it 
is our aim to carefully monitor the present situation especially regarding WNV, TOSV, 
and TBEV as potential emerging arboviral causes of encephalitis.  
The ENIVD has analyzed the present surveillance situation for viral 
encephalitis/meningitis in Europe by giving an overview of the existing 
epidemiological sources of information in the European Union (EU) Member States, 
mapping the laboratory capacity, and identifying key requirements for a possible 
future surveillance study at the European level. Therefore, we recommended that the 
introduction of a broad standard case definition and harmonized/standardized 
diagnostic algorithm using a multiplex-microarray system validated for a wide range 
of viruses may help discover the true incidence and etiological pattern of viral 
encephalitis/meningitis within each country. This would guarantee high performance 
and comparability of the results consistent with EQA programs. To improve 
surveillance, it is also important to quantify the extent of cases of unknown etiology, 
in order to allow a comparison of the data from each country and to identify possible 
weaknesses in the surveillance data. Therefore, clinicians must be motivated to 
report all cases of viral encephalitis/meningitis and to reach a definitive etiological 
diagnosis. A European study based on a close cooperation between clinicians, 
epidemiologists, and microbiologists will provide more accurate and timely data on 
viral CNS diseases which are of public health interest. Such an initiative could help 
increase case ascertainment, reduce the rate of unknown etiologies, develop and 
validate new diagnostic methods, improve recommendations and guidelines, and 
gain more valuable clinical and epidemiological data for research purposes than in 




The EQA studies performed by ENIVD showed that the assays used in most 
laboratories are focusing on the virus prototype strains that were predominant in 
recent years. Consequently, newly circulating strains like WNV lineage II, normally 
occurring in Africa, or the Siberian and Far Eastern subtypes of TBEV are not 
detected by these assays. Recently, WNV lineage II was detected in Hungary and 
Greece, while TBEV subtypes other than the European subtype are circulating in 
European countries, e.g. in the Baltic States and Finland. Based on the results of the 
EQA studies, an overview of the current diagnostic capacity of European laboratories 
was obtained and the laboratories with weaker performance received help and 
instructions to improve their work. For the future, there will be better insight into the 
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